BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 28375452)

  • 1. Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
    Davis LS; Reimold AM
    Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i100-i113. PubMed ID: 28375452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update οn the diagnosis and management of systemic lupus erythematosus.
    Fanouriakis A; Tziolos N; Bertsias G; Boumpas DT
    Ann Rheum Dis; 2021 Jan; 80(1):14-25. PubMed ID: 33051219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. It hasn't gone away: the problem of glucocorticoid use in lupus remains.
    Apostolopoulos D; Morand EF
    Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i114-i122. PubMed ID: 28013208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.
    Fanouriakis A; Mastorodemos V; Pamfil C; Papadaki E; Sidiropoulos P; Plaitakis A; Amoiridis G; Bertsias G; Boumpas DT
    Semin Arthritis Rheum; 2014 Jun; 43(6):751-8. PubMed ID: 24332007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapies in rheumatologic disorders.
    Miller AV; Ranatunga SK
    Med Clin North Am; 2012 May; 96(3):475-96, ix-x. PubMed ID: 22703852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging therapies in systemic lupus erythematous: from clinical trial to the real life.
    Zhang H; Chambers W; Sciascia S; Cuadrado MJ
    Expert Rev Clin Pharmacol; 2016; 9(5):681-94. PubMed ID: 26907827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.
    de Luca Montes RA; Huq M; Godfrey T; Oon S; Calderone A; Kandane-Rathnayake R; Louthrenoo W; Luo SF; Jan Wu YJ; Golder V; Lateef A; Navarra SV; Zamora L; Hamijoyo L; Sockalingam S; An Y; Li Z; Katsumata Y; Harigai M; Chan M; Goldblatt F; O'Neill S; Lau CS; Cho J; Hoi A; Karyekar CS; Morand EF; Nikpour M
    Adv Rheumatol; 2024 May; 64(1):38. PubMed ID: 38720354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus diagnosis and management.
    Thong B; Olsen NJ
    Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i3-i13. PubMed ID: 28013206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to treat refractory arthritis in lupus?
    Artifoni M; Puéchal X
    Joint Bone Spine; 2012 Jul; 79(4):347-50. PubMed ID: 22341583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab and lupus interstitial lung disease: friend or foe?
    Efthimiou P; Kukar M; Hersh A
    Int J Rheum Dis; 2011 Feb; 14(1):e3-4. PubMed ID: 21303472
    [No Abstract]   [Full Text] [Related]  

  • 12. The biology behind the new therapies for SLE.
    Ermann J; Bermas BL
    Int J Clin Pract; 2007 Dec; 61(12):2113-9. PubMed ID: 17997810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the use of existing therapies in lupus.
    Croyle L; Morand EF
    Int J Rheum Dis; 2015 Feb; 18(2):129-37. PubMed ID: 25884457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and novel therapeutics in the treatment of systemic lupus erythematosus.
    Yildirim-Toruner C; Diamond B
    J Allergy Clin Immunol; 2011 Feb; 127(2):303-12; quiz 313-4. PubMed ID: 21281862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From mechanism to therapies in systemic lupus erythematosus.
    Paley MA; Strand V; Kim AH
    Curr Opin Rheumatol; 2017 Mar; 29(2):178-186. PubMed ID: 28118202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.
    Trindade VC; Carneiro-Sampaio M; Bonfa E; Silva CA
    Paediatr Drugs; 2021 Jul; 23(4):331-347. PubMed ID: 34244988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug alternatives in therapy of neuropsychiatric systemic lupus erythematosus (NPSLE)].
    Harten P
    Med Klin (Munich); 2003 Jun; 98(6):344; author reply 344-5. PubMed ID: 12877108
    [No Abstract]   [Full Text] [Related]  

  • 18. [Allergo-immunology. Clinical immunology].
    Chizzolini C
    Rev Med Suisse; 2012 Jan; 8(323):11-3. PubMed ID: 22303732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovative management of lupus erythematosus.
    Knott HM; Martínez JD
    Dermatol Clin; 2010 Jul; 28(3):489-99. PubMed ID: 20510759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
    Fanouriakis A; Kostopoulou M; Andersen J; Aringer M; Arnaud L; Bae SC; Boletis J; Bruce IN; Cervera R; Doria A; Dörner T; Furie RA; Gladman DD; Houssiau FA; Inês LS; Jayne D; Kouloumas M; Kovács L; Mok CC; Morand EF; Moroni G; Mosca M; Mucke J; Mukhtyar CB; Nagy G; Navarra S; Parodis I; Pego-Reigosa JM; Petri M; Pons-Estel BA; Schneider M; Smolen JS; Svenungsson E; Tanaka Y; Tektonidou MG; Teng YO; Tincani A; Vital EM; van Vollenhoven RF; Wincup C; Bertsias G; Boumpas DT
    Ann Rheum Dis; 2024 Jan; 83(1):15-29. PubMed ID: 37827694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.